{"name":"Triazolam","slug":"triazolam","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Halcion","Clorazolam","Songar","Novidorm","Triazolamum","U-33,030","Triazolam civ","U-33030","U 33030","8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine"],"brands":[],"scraped":true,"has_structure":true,"cid":5556,"classes":[],"families":[{"name":"triazolobenzodiazepine","href":"/substituted/triazolobenzodiazepine"}],"physical":[{"label":"Molecular mass","value":"343.20 g/mol","copyable":false},{"label":"Appearance","value":"Tan crystals from 2-propanol","copyable":false},{"label":"Melting point","value":"233-235 °C","copyable":false},{"label":"Solubility","value":"4.53 mg/L","copyable":false},{"label":"Predicted LogP","value":"2.4","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>17</sub>H<sub>12</sub>Cl<sub>2</sub>N<sub>4</sub>","copyable":true},{"label":"IUPAC name","value":"8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","copyable":true},{"label":"SMILES","value":"CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl","copyable":true},{"label":"InChI","value":"InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3","copyable":true},{"label":"InChIKey","value":"JOFWLTCLBGQGBO-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"28911-01-5","copyable":true},{"label":"UNII","value":"1HM943223R","copyable":true},{"label":"PubChem CID","value":"5556","copyable":true}],"pharmacokinetics":[{"label":"Onset","value":"15–30 minutes<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false},{"label":"Elimination half-life","value":"1.5–5.5 hours","copyable":false},{"label":"Metabolism","value":"Liver","copyable":false},{"label":"Excretion","value":"Kidney","copyable":false},{"label":"Routes of administration","value":"By mouth","copyable":false}],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[{"reagent":"Zimmermann","reacts":true,"colors":["#ffffff","#d59aca","#50268d"],"description":"violet / purple"}],"atc":[{"code":"N","description":"Nervous system"},{"code":"N05","description":"Psycholeptics"},{"code":"N05C","description":"Hypnotics and sedatives"},{"code":"N05CD","description":"Benzodiazepine derivatives"},{"code":"N05CD05","description":""},{"code":"N05CD05","description":"Triazolam"}],"mesh":[{"name":"Adjuvants, Anesthesia","id":"M0001144"},{"name":"Anti-Anxiety Agents","id":"M0021771"},{"name":"GABA Modulators","id":"M0028093"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"CYP3A4","mechanisms":["induction","metabolism","inhibition"],"partners":192,"contraindicated":40},{"target":"GABRA1","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRA2","mechanisms":["shared target"],"partners":31,"contraindicated":0},{"target":"GABRA3","mechanisms":["shared target"],"partners":31,"contraindicated":0},{"target":"GABRA4","mechanisms":["shared target"],"partners":31,"contraindicated":0},{"target":"GABRA5","mechanisms":["shared target"],"partners":31,"contraindicated":0},{"target":"GABRA6","mechanisms":["shared target"],"partners":31,"contraindicated":0},{"target":"GABRB1","mechanisms":["shared target"],"partners":31,"contraindicated":0},{"target":"GABRB2","mechanisms":["shared target"],"partners":31,"contraindicated":0},{"target":"GABRB3","mechanisms":["shared target"],"partners":31,"contraindicated":0},{"target":"GABRD","mechanisms":["shared target"],"partners":31,"contraindicated":0},{"target":"GABRE","mechanisms":["shared target"],"partners":31,"contraindicated":0},{"target":"GABRG1","mechanisms":["shared target"],"partners":31,"contraindicated":0},{"target":"GABRG2","mechanisms":["shared target"],"partners":31,"contraindicated":0},{"target":"GABRG3","mechanisms":["shared target"],"partners":31,"contraindicated":0},{"target":"GABRP","mechanisms":["shared target"],"partners":31,"contraindicated":0},{"target":"GABRQ","mechanisms":["shared target"],"partners":31,"contraindicated":0}],"mechanism":"Benzodiazepines bind nonspecifically to bezodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABA<sub>A</sub>) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.","side_effects":{"drug_id":5556,"drug_name":"triazolam","url":"https://sideeffects.embl.de/drugs/5556/pt","atc_codes":["N05CD05"],"side_effects":[{"name":"Somnolence","cui":"C2830004"},{"name":"Headache","cui":"C0018681"},{"name":"Dizziness","cui":"C0012833"},{"name":"Lightheadedness","cui":"C0220870"},{"name":"Syncope","cui":"C0039070"},{"name":"Nervousness","cui":"C0027769"},{"name":"Tension","cui":"C0233494"},{"name":"Ataxia","cui":"C0004134"},{"name":"Nausea","cui":"C0027497"},{"name":"Vomiting","cui":"C0042963"},{"name":"Coordination abnormal","cui":"C0520966"},{"name":"Abdominal pain","cui":"C0000737"},{"name":"Gastrointestinal pain","cui":"C0687713"},{"name":"Aggression","cui":"C0001807"},{"name":"Amnesia","cui":"C0002622"},{"name":"Decreased appetite","cui":"C0232462"},{"name":"Anxiety","cui":"C0003467"},{"name":"Asthenia","cui":"C0004093"},{"name":"Fatigue","cui":"C0015672"},{"name":"Chest pain","cui":"C0008031"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Malaise","cui":"C0231218"},{"name":"Constipation","cui":"C0009806"},{"name":"Delusion","cui":"C0011253"},{"name":"Depersonalisation","cui":"C0011551"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Diarrhoea","cui":"C0011991"},{"name":"Drug abuse","cui":"C0013146"},{"name":"Dysarthria","cui":"C0013362"},{"name":"Slurred speech","cui":"C0234518"},{"name":"Osteoarthritis","cui":"C0029408"},{"name":"Dysgeusia","cui":"C0013378"},{"name":"Dyspnoea","cui":"C0013404"},{"name":"Oedema","cui":"C0013604"},{"name":"Flatulence","cui":"C0016204"},{"name":"Glossitis","cui":"C0017675"},{"name":"Hallucination","cui":"C0018524"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Hypertension","cui":"C0020538"},{"name":"Incontinence","cui":"C0021167"},{"name":"Irritability","cui":"C0022107"},{"name":"Jaundice","cui":"C0022346"},{"name":"Muscle spasms","cui":"C0037763"},{"name":"Muscle spasticity","cui":"C0026838"},{"name":"Nightmare","cui":"C0028084"},{"name":"Pain","cui":"C0030193"},{"name":"Palpitations","cui":"C0030252"},{"name":"Paraesthesia","cui":"C0030554"},{"name":"Pruritus","cui":"C0033774"},{"name":"Respiratory tract infection","cui":"C0035243"},{"name":"Sleep disorder","cui":"C0851578"},{"name":"Somnambulism","cui":"C0037672"},{"name":"Stomatitis","cui":"C0038362"},{"name":"Mouth irritation","cui":"C0235339"},{"name":"Shock","cui":"C0036974"},{"name":"Loss of consciousness","cui":"C0041657"},{"name":"Tachycardia","cui":"C0039231"},{"name":"Tinnitus","cui":"C0040264"},{"name":"Tremor","cui":"C0040822"},{"name":"Dry mouth","cui":"C0043352"},{"name":"Urinary retention","cui":"C0080274"},{"name":"Hepatic failure","cui":"C0085605"},{"name":"Agitation","cui":"C0085631"},{"name":"Mood swings","cui":"C0085633"},{"name":"Affect lability","cui":"C0233472"},{"name":"Drug withdrawal syndrome","cui":"C0152128"},{"name":"Depressed level of consciousness","cui":"C0549249"},{"name":"Consciousness clouding","cui":"C0683369"},{"name":"Muscular weakness","cui":"C0151786"},{"name":"Menstruation irregular","cui":"C0156404"},{"name":"Discomfort","cui":"C0234215"},{"name":"Ill-defined disorder","cui":"C2047937"},{"name":"Disorientation","cui":"C0233407"},{"name":"Thinking abnormal","cui":"C0233632"},{"name":"Mental disability","cui":"C1306341"},{"name":"Derealisation","cui":"C0233754"},{"name":"Memory impairment","cui":"C0233794"},{"name":"Anterograde amnesia","cui":"C0233795"},{"name":"Euphoric mood","cui":"C0235146"},{"name":"Eye irritation","cui":"C0235266"},{"name":"Glossodynia","cui":"C0017672"},{"name":"Dysuria","cui":"C0013428"},{"name":"Strangury","cui":"C0241705"},{"name":"Erythema","cui":"C0041834"},{"name":"Mania","cui":"C0338831"},{"name":"Dysaesthesia","cui":"C0392699"},{"name":"Insomnia","cui":"C0917801"},{"name":"Visual impairment","cui":"C3665347"},{"name":"Sexual dysfunction","cui":"C0549622"},{"name":"Hyperhidrosis","cui":"C0020458"},{"name":"Muscle tone disorder","cui":"C0851647"},{"name":"Deafness","cui":"C0011053"},{"name":"Hearing impaired","cui":"C1384666"}],"indications":[{"name":"Insomnia","cui":"C0917801"}]},"effects":null,"usernotes":[{"user":"bonzi","user_slug":"bonzi","external":false,"note":{"substance":"Triazolam","composite":false,"routes":[],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}},{"user":"nervewing","user_slug":"nervewing","external":false,"note":{"substance":"Triazolam","composite":false,"routes":[],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}}],"erowid":[],"reddit":[{"id":"5o1hp1","title":"A Lackluster Venture In to Barb-Land","author":"Lysergedelia","score":1,"posted_on":"2017-01-15","url":"https://reddit.com/r/tripreports/comments/5o1hp1/a_lackluster_venture_in_to_barbland/"}],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[]},{"jurisdiction":"Brazil","status":"B1","act":null,"refs":[4]},{"jurisdiction":"Canada","status":"Schedule IV","act":null,"refs":[]},{"jurisdiction":"Germany","status":"Prescription only/Anlage III","act":null,"refs":[]},{"jurisdiction":"New Zealand","status":"Class C5 (discontinued)","act":null,"refs":[]},{"jurisdiction":"United Kingdom","status":"Class C","act":"Misuse of Drugs Act 1971","refs":[]},{"jurisdiction":"United States","status":"Schedule IV","act":"Controlled Substances Act","refs":[]},{"jurisdiction":"United Nations","status":"Schedule IV narcotic","act":"Single Convention on Narcotic Drugs 1961","refs":[]},{"jurisdiction":"Other","status":"SE: Förteckning IV, In general: ℞ (Prescription only)","act":null,"refs":[5]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Triazolam"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/5556"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q412143"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00897"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL646"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A9674"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=28911-01-5"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0015034"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D00387"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID6046763"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Triazolam"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/1HM943223R"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/5556/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 5556, Triazolam. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/5556>https://pubchem.ncbi.nlm.nih.gov/compound/5556</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Triazolam. UNII: 1HM943223R. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/1HM943223R>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/1HM943223R</a>","What Is Triazolam Used For?. www.icliniq.com. 1 November 2022. <a href='https://www.icliniq.com/articles/drug-and-supplements/triazolam'>https://www.icliniq.com/articles/drug-and-supplements/triazolam</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>","Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika. Läkemedelsverket. <a href='https://www.lakemedelsverket.se/globalassets/dokument/lagar-och-regler/lvfs/lvfs-2011-10-konsoliderad.pdf'>https://www.lakemedelsverket.se/globalassets/dokument/lagar-och-regler/lvfs/lvfs-2011-10-konsoliderad.pdf</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 15:29:18","note":"no dosing statistics"},{"source":"drugspro","status":"ok","fetched_at":"2026-11-20 15:29:14","note":null},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 15:29:14","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 15:29:15","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 15:29:14","note":"hmdb.ca refused automated access to HMDB0015034"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 15:29:17","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 15:29:13","note":null},{"source":"reddit","status":"ok","fetched_at":"2026-11-20 15:29:14","note":null},{"source":"sider","status":"ok","fetched_at":"2026-11-20 15:29:14","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 15:29:14","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 15:29:14","note":null}],"description":"Triazolam is a  substance."}